NEWS AND EVENTS
Discover the latest news
We spoke with Prof. Paul O´Brien, CEO of ELAROS 24/7 Limited, the company behind the MammoScreen Project Lite App, asking questions from the perspective of...
If you are concerned about your breast cancer risk, especially because of a family history, that concern is understandable and it can be a helpful...
Whether you’ve been personally affected by breast cancer or simply want to learn more about prevention and early detection, having access to trustworthy information...
The Lite App was developed as part of the MammoScreen Project´s mission to make breast cancer screening more inclusive and accessible. This user-friendly mobile application...
Based in Sheffield, UK, ELAROS 24/7 Limited is a digital health company specialising in the development of software solutions that support patients, clinicians and researchers....
Our partners from UBT were invited to participate in the 2nd International Conference on Young Women’s Breast Cancer and Health , held on 15-16 November...
JulyMedica AI – The Conference 2026 will take place on 16 July at the Champalimaud Foundation in Lisbon, Portugal. Bringing together clinicians, researchers, healthcare innovators,...
In May 2024, the MammoScreen project held its first stakeholder workshop in Lisbon, bringing together healthcare professionals, researchers, policymakers and patient representatives to discuss the...
In this arcticle, we bring together two unique perspectives united by the shared mission of improving the future of breast cancer screening. We gathered questions...
Certain DNA mutations can significantly increase the risk of breast cancer and individuals with a first-degree relative (parent, sibling, or child) diagnosed with breast cancer...
One of the activities planned within the scope of the MammoScreen clinical investigation is the interim analysis, a data checkpoint and an opportunity to evaluate...
Led by Dr. Mohammad Ghavami, Professor of Telecommunications Engineering at London South Bank University (LSBU), the LSBU research team plays a key role in the...
MammoWave®, the technology being evaluated in the MammoScreen Project, uses microwave signals rather than X-rays to detect breast abnormalities. It operates in the 1 –...
The MammoScreen Project is improving the AI-driven algorithm used in the MammoWave® technology. The aim is to develop the AI-based model so that it detects...
Breast, cervical and colorectal cancers are the most common in Europe but are also the most treatable when detected at an early stage. That is...
October is the month to wear pink in support of all those affected by breast cancer. Celebrated globally as the Breast Cancer Awareness Month (BCAM),...
The San Francesco Convent, residence of the IMT School for Advanced Studies IMT Lucca, has been magnificently restored to offer state-of-the-art university campus buildings within...
We understand that joining a research study is a significant decision. Therefore, we ensure that participants fully understand the scope of the MammoScreen trial, its...
SESCAM (Servicio de Salud de Castilla-La Mancha) is the public health service responsible for managing healthcare across Castilla-La Mancha, Spain. Established in 2002, SESCAM provides...
The MammoScreen Project reached its mid-term milestone last November, and the Consortium took the opportunity to celebrate achievements and identify upcoming challenges. A key highlight...
The MammoScreen clinical trial is well under way and we are pleased to report significant progress in the recruitment of volunteers. Following the ethical and...
Mariana Coutinho, a young Portuguese patient advocate, shares her views and lived experience. Mariana began her work as a volunteer in 2018, at the Oncology...
Last 22, 23 and 24th of May, it was EVITA´s pleasure to welcome all the MammoScreen partners to Lisbon, a city known for its vibrant...
When creating an App, the key to success lies in understanding the basics: who is it for, how does it provide a benefit, and how...
Umbria Bioengineering Technologies (UBT) is an Italian company established in 2015 as a spin-off of the Department of Physics and Geology (FISGEO) at the University...
Dear Reader, We invite you to join us in another exciting Newsletter about the MammoScreen journey. Learn how our collaborative efforts and innovative solutions contribute...
The MammoScreen project consortium is glad to officially announce the initiation of the clinical study for the validation of MammoWave® for screening purposes. The aim...
MAMMOSCREEN is a proud partner of the Cluster on Cancer “Prevention and Early Detection”, which has launched its LinkedIn channel. The new logo of the...
Dear Reader, A warm welcome to our Newsletter. In December 2022, the MammoScreen Project was awarded 7 million euros by the European Health and Digital...
Siobhán Freeney is the coordinator of the MammoScreen Project Patient Advisory Group (PAG). She was diagnosed with stage 3 Invasive Lobular Carcinoma (ILC) in December...
Meet the MAMMOSCREEN Coordination and Management Team at Fondazione Toscana Life Sciences (TLS). Fondazione Toscana Life Sciences is a non-profit research organization based in Siena,...
The MammoScreen clinical study involves 9 centres in five different European countries – Italy, Poland, Portugal, Spain and Switzerland – and will recruit 10.000 women...
MammoWave works differently from traditional methods that use X-rays. The device generates a qualitative representation of the breast tissues by processing very low power (<1...
https://youtu.be/ZU7uH5s_HXs?si=hiMB3RCTLq_BDj84 MAMMOSCREEN team is thrilled to launch the first video of the project! The MAMMOSCREEN initial video is part of the dissemination and communication strategy...
Last 22 and 23 November 2023, all the partners, the members of the Scientific and Ethics Advisory Boards and Patient Advisory Group involved in the...
The first Annual Meeting of the “Prevention and early detection (Screening)” Cluster of projects will be held on September 7th in San Sebastian, Spain. In...
Calling all women: Be heard and make a difference! Are you a healthy woman, someone with a predisposition for hereditary cancer, or a brave fighter...
The first MammoScreen Webinar with Patient Advocates and Patient Advocay Groups is scheduled on 4th September 2023, 13.30-15 PM CEST, via ZOOM. The primary purpose...
The PhD research project will last 3 years and will be carried out in the framework of MAMMOSCREEN project. MAMMOSCREEN makes available 1 PhD fellowship...
Fondazione Toscana Life Sciences, MAMMOSCREEN’s project coordinator, has a new open position! Fondazione Toscana Life Sciences, with a view to the strong expansion of its...
It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects cluster on cancer “Prevention and early detection (Screening)”. Under...
All MAMMOSCREEN partners have agreed on the dates of the meeting, to be held on November 22 and 23 in Toledo, Spain, and will be...
